Table 2 Perioperative data, type of surgery, and histology.
From: Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgery
Perioperative data, N (%) | A (n = 39; 34.2%) | B (n = 37; 32.5%) | C (n = 38; 33.3%) | A vs C P* | B vs C P* | A vs B P* |
|---|---|---|---|---|---|---|
Quadrantectomy | 3 (7.7) | 5 (13.5) | 2 (5.3) | 1 | 0.26 | 0.47 |
Quadrantectomy + SLNB | 35 (89.7) | 28 (75.7) | 32 (84.2) | 0.52 | 0.40 | 0.13 |
Quadrantectomy + ALND | / | 2 (5.4) | 3 (7.9) | 0.12 | 1 | 0.23 |
Quadrantectomy + SLNB + ALND | 1 (2.6) | 2 (5.4) | 1 (2.6) | 1 | 0.61 | 0.61 |
Operative time (min) | 115 ± 29 | 118 ± 26 | 124 ± 35 | 0.15 | 0.28 | 0.65 |
Hospital stay (hours) | 30 ± 11 | 34 ± 12 | 35 ± 14 | 0.23 | 0.84 | 0.27 |
DCIS | 14 (35.9) | 12 (32.4) | 13 (34.2) | 1 | 1 | 0.81 |
IDC | 21 (53.8) | 22 (59.5) | 21 (55.3) | 1 | 0.82 | 0.65 |
ILC | 4 (10.3) | 3 (8.1) | 4 (10.5) | 1 | 1 | 1 |
Luminal A | 12 (30.8) | 20 (54.1) | 10 (26.3) | 0.80 | 0.21 | 0.06 |
Luminal B | 9 (30.7) | 6 (16.2) | 13 (34.2) | 0.32 | 0.11 | 0.57 |
HER2-enriched | / | / | 1 (2.6) | 0.49 | 1 | 1 |
Basal like | 1 (2.6) | 2 (5.4) | 1 (2.6) | 1 | 0.61 | 0.61 |
